PLK1抑制通过抑制自噬增强乳腺癌细胞放射敏感性
该研究探讨PLK1抑制能否增强乳腺癌细胞放射敏感性。方法包括PLK1 siRNA或抑制剂GSK461364处理乳腺癌细胞,评估增殖、细胞周期、DNA损伤、自噬和活性氧,并用异种移植小鼠模型验证。
要点
- PLK1抑制可增强乳腺癌细胞对辐射的敏感性。
- 机制涉及抑制辐射诱导的自噬和活性氧下调。
- PLK1与LC3在乳腺癌组织中表达正相关。
核心结论
- PLK1抑制通过抑制辐射诱导的自噬增强乳腺癌细胞放射敏感性。
- 抑制PLK1是乳腺癌放射增敏的潜在策略。
研究设计与样本
- 采用乳腺癌细胞,以PLK1小干扰RNA或PLK1抑制剂GSK461364处理。
- 使用集落形成实验评估细胞增殖,流式细胞术分析细胞周期。
- 通过免疫荧光、Western blot和流式细胞术检测DNA损伤、自噬和活性氧。
- 采用克隆生存实验确定PLK1抑制对细胞放射敏感性的影响。
- 使用乳腺癌细胞异种移植小鼠模型研究PLK1抑制与照射的潜在协同效应,并通过免疫组化评估乳腺癌组织中PLK1和LC3表达。
主要发现
- PLK1抑制显著抑制乳腺癌细胞增殖并增加放射敏感性。
- 机制上,PLK1抑制导致辐射诱导的活性氧和自噬下调,从而增加放射敏感性。
临床怎么用
- PLK1抑制可能作为乳腺癌放射增敏策略,尤其与自噬抑制相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Polo-like kinase 1 (PLK1) is a protein kinase that is overexpressed in breast cancer and may represent an attractive target for breast cancer treatment. However, few studies have investigated the relationship between PLK1 and radiosensitivity in breast cancer. Here, we attempted to explore whether PLK1 inhibition could sensitize breast cancer cells to radiation. METHODS AND MATERIALS: Breast cancer cells were treated with PLK1 small interference RNA or the PLK1-inhibitor, GSK461364. Cell proliferation was assessed using a colony formation assay. Cell cycle analyses were performed by flow cytometry. DNA damage, autophagy, and reactive oxygen species induced by ionizing radiation were detected by immunofluorescence, Western blot, and flow cytometry, respectively. Microtubule-associated protein 1 light chain 3 alpha (LC3) puncta were detected using an immunofluorescence assay. A clonogenic survival assay was used to determine the effect of PLK1 inhibition on cell radiosensitivity. A xenograft mouse model of breast cancer cells was used to investigate the potential synergistic effects of PLK1 inhibition and irradiation in vivo. Finally, the expression of PLK1 and LC3 in the breast cancer tissues was evaluated by immunohistochemistry. RESULTS: PLK1 inhibition significantly suppressed the proliferation and increased the radiosensitivity of breast cancer cells. Pharmacologic inhibition of PLK1 by the selective inhibitor, GSK461364, enhanced the radiosensitivity of breast cancer cells in vivo (n = 4, P = .002). Mechanistically, PLK1 inhibition led to the downregulation of radiation-induced reactive oxygen species and autophagy, thereby increasing the radiosensitivity of breast cancer cells. Additionally, we detected a positive correlation between the expression of PLK1 and LC3 in human breast cancer samples (n = 102, R = 0.486, P = .005). CONCLUSIONS: Our findings indicate that PLK1 inhibition enhances the radiosensitivity of breast cancer cells in a manner associated with the suppression of radiation-induced autophagy. The inhibition of PLK1 represents a promising strategy for radiosensitizing breast cancer.
引用
- Wang B, Huang X, Liang H, et al. PLK1 Inhibition Sensitizes Breast Cancer Cells to Radiation via Suppressing Autophagy. Int J Radiat Oncol Biol Phys. 2021. PMID: 33621661. doi:10.1016/j.ijrobp.2021.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。